FDA drug approval lifts biotech Neuren to $1b valuation
MELBOURNE: Biotech Neuren Pharmaceuticals surged to a $1 billion valuation yesterday after the ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
